A study led by the Instituto de Tecnología Química (UPV-CSIC) has identified new bioactive compounds that could help in the fight against breast cancer
Despite advances in the diagnosis and treatment of breast cancer, it remains a challenging disease with a high mortality rate. The search for new compounds and therapies is essential to improve the survival and quality of life of affected individuals.
In this regard, a multidisciplinary team from the Instituto de Tecnología Química (UPV-CSIC) and Louisiana State University (LSU) in the United States has demonstrated for the first time the anti-tumor properties of structural analogs of various natural metabolites in breast cancer models. Their results have been published in the journal Cancers.
